MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2017 International Congress

    Analysis of related factors of occurrence of dementia in Parkinson’s disease using the application form of Parkinson’s disease provided by the specific diseases treatment research program of Ministry of Health, Labor and Welfare of Japan

    K. Konaka, M. Mihara, H. Mochizuki (Suita, Japan)

    Objective: Dementia has now been noticed as a significant non-motor symptom of Parkinson's disease (PD). We attempted to analyze the relation between the occurrence of…
  • 2017 International Congress

    An unusual case of sporadic Creutzfeld Jacob disease presenting as acute neuropathy

    R. Hanumanthu, A. Alchaki, A. Nyaboga, H. Ghuman, J. Chen, E. Feinstein (Newark, NJ, USA)

    Objective: To describe an unusual case of sporadic Creutzfeld Jacob Disease (CJD) that initially presented with ascending tingling of lower extremities. Background: Prion diseases are…
  • 2017 International Congress

    White matter microstructural damage as predictor of cognitive decline in Parkinson’s disease

    T. Stojkovic, E. Stefanova, F. Agosta, S. Galantucci, I. Stankovic, V. Markovic, E. Canu, M. Copetti, M. Filippi, V. Kostic (Belgrade, Serbia)

    Objective: To investigate patterns of cortical and white matter (WM) changes associated with progression to mild cognitive impairment (MCI) or dementia in patients with Parkinson’s…
  • 2017 International Congress

    Clinical Predictors of Dementia and Other Non-Motor Symptoms in Parkinson’s Disease

    D. Lichter, S. Finnegan (Buffalo, NY, USA)

    Objective: To clarify clinical predictors (pX) of dementia and other non-motor symptoms (NMS) in Parkinson's disease (PD). Background: The postural instability-gait disorder (PIGD) phenotype has…
  • 2017 International Congress

    Mild cognitive impairment in newly diagnosed Parkinson’s disease: a three year follow up

    R. Lawson, A. Yarnall, G. Duncan, D. Breen, T. Khoo, C. Williams-Gray, R. Barker, D. Burn (Newcastle Upon Tyne, United Kingdom)

    Objective: To evaluate the stability of mild cognitive impairment in Parkinson’s disease (PD-MCI) over time to determine its clinical utility as a marker of disease.…
  • 2017 International Congress

    Higher risk of cognitive impairment in Parkinson’s disease with comorbid diabetes

    P. Schmidt, F. Cubillos, K. Lyons, C. Marras, T. Davis, E. Nelson, M. Okun (Miami, FL, USA)

    Objective: To determine the risk of cognitive impairment in individuals with Parkinson’s disease (PD) and diabetes. Background: Diabetes is associated with risk of cognitive impairment…
  • 2016 International Congress

    Clinical profile of Parkinson’s disease at the neurology department of Point G Teaching Hospital

    T. Coulibaly, A.S. Sissoko, T. Coulibaly, L. Guida, K. Mamadou, G.C. Oumar (Bamako, Mali)

    Objective: To determine the frequency and clinical features of PD at the neurology department of Point G Teaching Hospital. Background: PD results from loss of…
  • 2016 International Congress

    Disruption of functional connectivity in Parkinson’s disease patients presenting phonemic fluency impairment

    K. Kawabata, H. Watanabe, E. Bagarinao, N. Yoneyama, K. Hara, R. Ohdake, K. Imai, M. Masuda, T. Yokoi, T. Tsuboi, M. Ito, N. Atsuta, M. Katsuno, G. Sobue (Nagoya, Japan)

    Objective: This study was designed to clarify the changes of detailed functional connectivity in association with phonemic fluency deficits in Parkinson's disease (PD) patients using…
  • 2016 International Congress

    Analysis of cognitive disorders of Parkinson’s disease (PD) in the comparative aspect

    S. Lukmonov, D. Tolibov, A. Sobirov, F. Yunusov, D. Jalilov, K. Abdukhalimova, A. Kalendarev (Tashkent, Uzbekistan)

    Objective: Purpose of investigation was to conduct a comparative assessment of cognitive impairment in Parkinson's disease. Background: According to modern concepts, parkinsonism - is not…
  • 2016 International Congress

    Grey matter atrophy associated with the progression of cognitive decline in Parkinson’s disease (PD)

    M. Chondrogiorgi, L.G. Astrakas, A.K. Zikou, M.I. Argyropoulou, S. Konitsiotis (Ioannina, Greece)

    Objective: To investigate the pattern of grey matter (GM) atrophy associated with cognitive decline in PD by use of voxel-based morphometry (VBM) analysis. Background: Loss…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley